The FDA cleared a new round of Covid-19 boosters from Moderna and Pfizer/BioNTech that this time target the KP.2 variant.
The updated vaccines are expected …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The FDA handed a complete response letter (CRL) on Wednesday to Merck for its cough drug gefapixant following an adcomm that voted against the drug
Mean rates of colorectal cancer (CRC) screening tripled among average-risk individuals 45-49 years old after the U.S. Preventive Services Task Force (USPSTF) issued a recommendation
Ascentage Pharma, a Hong Kong-listed blood cancer biotech, is planning a dual listing in the US as it prepares for additional drug launches, it …